Positive 12-month data from VDPHL01 hair loss study

Veradermics reported deepened hair growth in Stage 3 male pattern hair loss study with the extended-release minoxidil formulation. The results position VDPHL01 to become the first FDA-approved oral pill in nearly 30 years for male pattern hair loss.